Carl Zeiss Meditec AG/ DE0005313704 /
| 2024-11-12 12:16:47 PM | Chg. +0.68 | Volume | Bid2024-09-30 | Ask2024-07-19 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 58.80EUR | +1.16% | 102 Turnover: 5,991.08 |
-Bid Size: - | -Ask Size: - | 5.15 bill.EUR | 1.91% | 17.72 |
Assets
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 58.7000 | 62.6000 | 116.8000 | 135.3000 | 199.6000 | ||||||
| Intangible Assets | 68.5000 | 74.1000 | 144.3000 | 137.4000 | 153.7000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 415.2000 | 411 | 717.8000 | 720.5000 | 792 | ||||||
| Inventories | 234.3000 | 248.1000 | 268.3000 | 286.4000 | 286.4000 | ||||||
| Accounts Receivable | 195.3000 | 192.3000 | 205.8000 | 165.2000 | 185.9000 | ||||||
| Cash and Cash Equivalents | 3.9000 | 6.7000 | 22.6000 | 5.2000 | 7.4000 | ||||||
| Current Assets | 1,207.9000 | 1,251.1000 | 1,304.3000 | 1,289.5000 | 1,604 | ||||||
| Total Assets | 1,623.1000 | 1,662.1000 | 2,022.1000 | 2,013.3000 | 2,396 | ||||||
Liabilities
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 64.9000 | 67.4000 | 83.5000 | 55.1000 | 98.2000 | ||||||
| Long-term debt | .6000 | - | 109 | 87.5000 | 76.5000 | ||||||
| Liabilities to Banks | 23.8000 | 21.1000 | 129.1000 | 107.9000 | 148.2000 | ||||||
| Provisions | 24.7000 | 27.7000 | 51.2000 | 44 | 42.7000 | ||||||
| Liabilities | 381.4000 | 347.4000 | 605.2000 | 562.7000 | 718.6000 | ||||||
| Share Capital | 89.4410 | 89.4410 | 89.4410 | 89.4410 | 89.4410 | ||||||
| Total Equity | 1,215.4000 | 1,293.5000 | 1,398.4000 | 1,431.7000 | 1,659.3000 | ||||||
| Minority Interests | 26.4000 | 21.2000 | 18.5000 | 18.8000 | 18.1000 | ||||||
| Total liabilities equity | 1,623.1000 | 1,662.1000 | 2,022.1000 | 2,013.3000 | 2,396 | ||||||
Income Statement
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,189.9000 | 1,280.9000 | 1,459.3000 | 1,335.5000 | 1,646.8000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 180.8000 | 197.1000 | 264.7000 | 177.6000 | 373.6000 | ||||||
| Interest Income | -.8000 | -1.1000 | -5.9000 | -25.8000 | -7 | ||||||
| Income Before Taxes | 188.6000 | 179.2000 | 229.9000 | 178.7000 | 339.1000 | ||||||
| Income Taxes | 52.8000 | 53 | 69.3000 | 55.3000 | 101.5000 | ||||||
| Minority Interests Profit | -1.3000 | .2000 | -.8000 | -1 | -1.2000 | ||||||
| Net Income | 134.4000 | 126.5000 | 159.8000 | 122.4000 | 236.3000 | ||||||
Per Share
Cash Flow
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 37.7000 | 187.2000 | 219.6000 | 178.5000 | 362.7000 | ||||||
| Cash Flow from Investing Activities | -55.9000 | -28.9000 | -145.8000 | -71.9000 | -75.2000 | ||||||
| Cash Flow from Financing | 14.5000 | -157.2000 | -58.6000 | -123 | -285.9000 | ||||||
| Decrease / Increase in Cash | -4.8000 | 2.8000 | 16 | -17.4000 | 1.2000 | ||||||
| Employees | 2,958 | 3,048 | 3,232 | 3,290 | 3,531 | ||||||
